ADLYXINE

sanofi-aventis canada inc🇨🇦 Health Canada

Approval Id: a10bf4ac97eb3340
Drug Approval Canada Name: ADLYXINE
Product Name: ADLYXINE
Status: Cancelled Post Market
Status Date: 2023-09-15
Original Market Date: 2017-09-12
Din: 02464284
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription
Ahfs: 68:20.06
Atc Original: A10BJ03 LIXISENATIDE
Atc Name: a 10 bj 03
Aig Number: 0159090004
Company Name: sanofi-aventis canada inc
Company Address: 1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4

LIXISENATIDE

20 MCG / ACT

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a10bf4ac97eb3340

Type

Standard